1611 related articles for article (PubMed ID: 23721951)
1. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China.
Wang Z; Xu M; Hu Z; Hultström M; Lai E
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1015-21. PubMed ID: 25003744
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
Wang Z; Xu M; Hu Z; Shrestha UK
Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
[TBL] [Abstract][Full Text] [Related]
4. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China.
Wang Z; Xia B; Ma C; Hu Z; Chen X; Cao P
Postgrad Med J; 2007 Mar; 83(977):192-5. PubMed ID: 17344575
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
9. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
10. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
11. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
12. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Lu H; Zeng L; Liang B; Shu X; Xie D
Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
[TBL] [Abstract][Full Text] [Related]
14. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
Li H; Wang YJ; Tan K; Zeng L; Liu L; Liu FJ; Zhou TY; Chen EQ; Tang H
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):377-82. PubMed ID: 19666406
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
18. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
19. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
20. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
